The Patient Protection and Affordable Care Act: The impact on urologic cancer care

Abstract In March 2010, the Patient Protection and Affordable Care Act as well as its amendments were signed into law. This sweeping legislation was aimed at controlling spiraling healthcare costs and redressing significant disparities in healthcare access and quality. Cancer diagnoses and their tre...

Full description

Saved in:
Bibliographic Details
Published in:Urologic oncology 2013-10, Vol.31 (7), p.980-984
Main Authors: Keegan, Kirk A., M.D, Penson, David F., M.D., M.P.H
Format: Article
Language:English
Subjects:
Accountable Care Act (ACA)
Accountable Care Organizations (ACO)
Accountable Care Organizations - economics
Accountable Care Organizations - legislation & jurisprudence
Health Care Costs - legislation & jurisprudence
Health Care Education and Reform Act
Health Services Accessibility - economics
Health Services Accessibility - legislation & jurisprudence
Humans
Medicaid - economics
Medicaid - legislation & jurisprudence
Outcome Assessment, Health Care - economics
Patient Centered Outcomes Research Institute (PCORI)
Patient Protection and Affordable Care Act
United States
Urologic Neoplasms - economics
Urologic Neoplasms - therapy
Urologic oncology
Urology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract In March 2010, the Patient Protection and Affordable Care Act as well as its amendments were signed into law. This sweeping legislation was aimed at controlling spiraling healthcare costs and redressing significant disparities in healthcare access and quality. Cancer diagnoses and their treatments constitute a large component of rising healthcare expenditures and, not surprisingly, the legislation will have a significant influence on cancer care in the USA. Because genitourinary malignancies represent an impressive 25% of all cancer diagnoses per year, this legislation could have a profound impact on urologic oncology. To this end, we will present key components of this landmark legislation, including the proposed expansion to Medicaid coverage, the projected role of Accountable Care Organizations, the expected creation of quality reporting systems, the formation of an independent Patient-Centered Outcomes Research Institute, and enhanced regulation on physician-owned practices. We will specifically address the anticipated effect of these changes on urologic cancer care. Briefly, the legal ramifications and current barriers to the statutes will be examined.
ISSN:1078-1439
1873-2496
DOI:10.1016/j.urolonc.2012.01.007